30038 Federal Register / Vol. 75, No. 103 / Friday, May 28, 2010 / Notices 

TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1—Continued 

21 CFR 

Section No. 

FDA 

Form No. 

No. of 

Respondents 

Annual Frequency 

per Response 

Total Annual 

Responses 

Hours per 

Response Total Hours 

1.285(i) None 1 1 1 1 1 

Prior Notice Requests for Review and Post-hold Submissions Subtotal 9 

Total Hours Annually 1,859,474 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

2To avoid double-counting, an estimated 396,416 burden hours already accounted for in the Importer’s Entry Notice information collection approved under OMB control number 0910–0046 are not included in this total. 3The term ‘‘Form FDA 3540’’ refers to the electronic system known as the FDA PN System Interface, which is available at http:// 

www.access.fda.gov. 

This estimate is based on FDA’s 

experience and the average number of 

prior notice submissions, cancellations, 

and requests for review received in the 

past 3 years. 

On November 7, 2008, FDA and CBP 

issued the prior notice final rule (73 FR 

66294), which finalized the prior notice 

interim final rule (IFR) (68 FR 58894, 

October 10, 2003). From the IFR to the 

final rule, FDA removed a few of the 

required prior notice data elements. 

Specifically, submitters no longer need 

to include the fax number of the 

submitter and transmitter, the 

anticipated border crossing, the country 

of the carrier, or the 6-digit HTS code 

in their prior notices. Other changes 

include the addition of the registration 

number of the transshipper for articles 

of food for transshipment, storage and 

export, or manipulation and export; 

flexibility in submitting the registration 

number and the city and country of the 

manufacturer and shipper instead of full 

addresses of these entities; and the 

option of submitting the tracking 

number for articles of food arriving by 

express consignment instead of 

anticipated arrival information when 

the prior notice is submitted through PN 

System Interface (73 FR 66294 at 

66402). 

Accordingly, FDA has reduced its 

estimate of the hours per response for 

prior notices received through ABI/ACS 

from 10 minutes, or 0.167 hours, per 

notice, to 9 minutes, or 0.15 hours, per 

notice. FDA received 8,144,419 prior 

notices through ABI/ACS during 2007; 

8,266,200 during 2008; and 5,221,549 as 

of August 26, 2009. Based on this 

experience, FDA estimates that 

approximately 6,500 users of ABI/ACS 

will submit an average of 1,290 prior 

notices annually, for a total of 8,385,000 

prior notices received annually through 

ABI/ACS. FDA estimates the reporting 

burden for a prior notice submitted 

through ABI/ACS to be 9 minutes, or 

0.15 hours, per notice, for a total burden 

of 1,257,750 hours. This estimate takes 

into consideration the burden hours 

already counted in the information 

collection approval for FDA’s importer’s 

entry notice, as previously discussed in 

this document. 

FDA has also reduced its estimate of 

the hours per response for prior notices 

received through the PN System 

Interface from 23 minutes to 22 minutes. 

FDA received 1,744,287 prior notices 

through the PN System Interface during 

2007; 1,662,033 during 2008; and 

989,708 as of August 26, 2009. Based on 

this experience, FDA estimates that 

approximately 21,500 registered users of 

the PN System Interface will submit an 

average of 73 prior notices annually, for 

a total of 1,569,500 prior notices 

received annually through the PN 

System Interface. FDA estimates the 

reporting burden for a prior notice 

submitted through the PN System 

Interface to be 22 minutes, or 0.366 

hours (rounded to 0.37 hours), per 

notice, for a total burden of 580,715 

hours. 

FDA received 16,215 cancellations of 

prior notices through ABI/ACS during 

2007; 16,673 during 2008; and 16,045 as 

of August 26, 2009. Based on this 

experience, FDA estimates that 

approximately 6,500 users of ABI/ACS 

will submit an average of 2.64 (rounded 

to 3) cancellations annually, for a total 

of 19,500 cancellations received 

annually through ABI/ACS. FDA 

estimates the reporting burden for a 

cancellation submitted through ABI/ 

ACS to be 15 minutes, or 0.25 hours, per 

cancellation, for a total burden of 4,875 

hours. 

FDA received 58,345 cancellations of 

prior notices through the PN System 

Interface during 2007; 63,779 during 

2008; and 55,019 as of August 26, 2009. 

Based on this experience, FDA estimates 

that approximately 21,500 registered 

users of the PN System Interface will 

submit an average of 3.24 (rounded to 3) 

cancellations annually, for a total of 

64,500 cancellations received annually 

through the PN System Interface. FDA 

estimates the reporting burden for a 

cancellation submitted through the PN 

System Interface to be 15 minutes, or 

0.25 hours, per cancellation, for a total 

burden of 16,125 hours. 

FDA has not received any requests for 

review under §§ 1.283(d) or 1.285(j) in 

the last 3 years (2007 through August 

26, 2009); therefore, the agency 

estimates that one or fewer requests for 

review will be submitted annually. FDA 

estimates that it will take a requestor 

about 8 hours to prepare the factual and 

legal information necessary to prepare a 

request for review. Thus, FDA has 

estimated a total reporting burden of 8 

hours. 

FDA has not received any post-hold 

submissions under § 1.285(i) in the last 

3 years (2007 through August 26, 2009); 

therefore, the agency estimates that one 

or fewer post-hold submissions will be 

submitted annually. FDA estimates that 

it will take about 1 hour to prepare the 

written notification described in 

§ 1.285(i)(2)(i). Thus, FDA has estimated 

a total reporting burden of 1 hour. 

Dated: May 24, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–12866 Filed 5–27–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Office of Administration; Matching 

Requirements on Grants Awarded 

Under Children’s Bureau Funding 

Opportunity Announcement for Fiscal 

Year 2010 

AGENCY: Division of Grants Policy, 

Office of Financial Services, Office of 

Administration, Administration for 

Children and Families (ACF), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice. 

CFDA Number: 93.648. 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 103 / Friday, May 28, 2010 / Notices 30039 

Legislative Authority: Section 426 of 

the Social Security Act [42 U.S.C. 

626(a)(2)]. 

SUMMARY: The Administration for 

Children and Families (ACF) hereby 

gives notice to the public that the 

following program within the Agency 

will administratively impose a matching 

requirement on grants awarded under 

the following program title and funding 

opportunity announcement for Fiscal 

Year 2010: 

Program office Funding opportunity number 

Funding opportunity title Fiscal 

year Program title CFDA number Match percentage Composition of match 

Administration for 

Children, Youth 

and Families— 

Children’s Bureau.

HHS–2010–ACF– 

ACYF–CA– 

0022.

Initiative to Reduce LongTerm Foster 

Care.

2010 Child Welfare 

Training.

93.648 10 percent of 

Total Approved 

Project Cost.

Cash and In-Kind. 

Historically, ACF has found that the 

imposition of a matching requirement 

on awards under certain programs result 

in an increased level of community 

support and, often, a higher profile in 

the community. This can contribute to 

the success and sustainability of the 

project. The Fiscal Year 2010 funding 

opportunity announcement for the 

Initiative to Reduce Long-Term Foster 

Care program will advise applicants on 

the percentage of funds that must be 

contributed through non-Federal 

resources, the composition of the match, 

and whether the merit of the match will 

be taken into consideration as a 

criterion in the competitive review. The 

administratively imposed matching 

requirement will apply only to new 

grants and their continuation grants, 

awarded under funding opportunity 

announcement HHS–2010–ACF–ACYF– 

CA–0022. 

This matching requirement does not 

represent an addition to any existing 

matching requirements on awards made 

under other funding opportunity 

announcements issued in Fiscal Year 

2008 or before. The amount and 

acceptable types of non-Federal 

resources allowed is not negotiable. 

However, matching may be provided as 

direct or indirect costs. Specific 

information related to the matching 

requirement and the competitive review 

process will be provided in the 

published funding opportunity 

announcement. Any unmatched Federal 

funds will be disallowed. Costs borne by 

matching contributions are subject to 

the regulations governing allowability 

found under 45 CFR 74.23 and 45 CFR 

92.24. 

Notices of planned grant 

opportunities proposed by HHS’s 

Operating Divisions are available at the 

HHS Forecast Web site. Each Forecast 

record contains actual or estimated 

dates and funding levels for grants that 

the agency intends to award during the 

fiscal year. Additional details about 

ACF planned FY 2010 funding 

opportunity announcements can be 

found on the Grants Forecast Web site 

at http://www.hhs.gov/grantsforecast/. 

Published ACF funding opportunity 

announcements are available on http:// 

www.Grants.gov and on the ACF Grant 

Opportunities Web page at http:// 

www.acf.hhs.gov/grants/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Karen Shields, Grants Policy Specialist, 

Office of Administration, Division of 

Grants Policy, 370 L’Enfant Promenade, 

SW., 6th Floor East, Washington, DC 

20447, or by telephone at 202–401–5112 

or karen.shields@acf.hhs.gov. 

February 24, 2010. 

Tony Hardy, 

Acting Deputy Assistant Secretary for 

Administration, Administration for Children 

and Families. 

[FR Doc. 2010–12826 Filed 5–27–10; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; K–12 Diabetes 

Prevention Curriculum Development. 

Date: June 16, 2010. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Carol J. Goter-Robinson, 

PhD, Scientific Review Officer, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 748, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–7791, 

goterrobinsonc@extra.niddk.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: May 24, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–12923 Filed 5–27–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary 

and Alternative Medicine; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 


jlentini on DSKJ8SOYB1PROD with NOTICES